Clinical Trial Update: Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing liposomal bupivacaine for pain management in ORIF of midshaft clavicle fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clavicle Fracture

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Minnesota | Conditions: Clavicle Fracture | Phase 4 | Status: WITHDRAWN